1.
Seah J-A, Sridhar S, Wood L, Blais N, North S, Rahim Y, Ruether D, Black P, Zlotta AR. Neoadjuvant chemotherapy (NC) should be administered to fit patients with newly diagnosed, potentially resectable muscle-invasive urothelial cancer (MIUC) of the bladder – A 2013 CAGMO Consensus Statement and Call for a Streamlined Referral Process. CUAJ [Internet]. 2013 Oct. 9 [cited 2024 Mar. 28];7(9-10):312-8. Available from: https://cuaj.ca/index.php/journal/article/view/1506